New knee pain pill faces off against standard treatment
NCT ID NCT07203547
First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 31 times
Summary
This study compares a new tablet called Laybon to an existing one (Layla) for knee osteoarthritis pain. About 172 adults aged 40 to 80 with knee arthritis will take either Laybon or Layla for 8 weeks. The main goal is to see if Laybon works as well as Layla at reducing knee pain during activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.